GGrantIndex
← Leaderboards

Aaron Hamvas

Washington University

$9,249,473
Attributed
$21,114,268
Total exposure
10
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.3M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,114,268 · 10

By mechanism

UG3$5,742,893 · 1
R01$5,270,496 · 2
UH3$5,019,949 · 1
U01$4,076,668 · 2
UG1$990,437 · 1
P41$13,825 · 3

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Premature

Research focus

PrematureInfantChildPregnancyNeonatalMemberLifePremature BirthResilienceMorbidity - Disease RateFutureBronchopulmonary DysplasiaLungChronicPathogenesisPostnatalSensorySeveritiesInsightAffectEarly IdentificationFamilyMothersParticipant

Grant awards (27)

Enriching ECHO Cohorts with High-risk Pregnancies and Children with Health Challenges (Enriching ECHO)$5,019,949
UH3 · FY2025 · OD
Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD)$1,906,644
R01 · FY2025 · HL · contact PI
Neonatal Research Network: the Lurie Children's - Northwestern University Study Center$328,079
UG1 · FY2025 · HD · contact PI
Enriching ECHO Cohorts with High-risk Pregnancies and Children with Disabilities (Enriching ECHO)$3,669,385
UG3 · FY2024 · OD
Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD)$2,070,206
R01 · FY2024 · HL · contact PI
Neonatal Research Network: the Lurie Children's - Northwestern University Study Center$331,179
UG1 · FY2024 · HD · contact PI
Enriching ECHO Cohorts with High-risk Pregnancies and Children with Disabilities (Enriching ECHO)$2,073,508
UG3 · FY2023 · OD
Neonatal Research Network: the Lurie Children's - Northwestern University Study Center$331,179
UG1 · FY2023 · HD · contact PI
Integrated analysis of autonomic biomarkers in prematurity-related ventilatory control: Determination of neurorespiratory maturation and predictors of co-morbidity risk$530,569
U01 · FY2020 · HL · contact PI
Integrated analysis of autonomic biomarkers in prematurity-related ventilatory control: Determination of neurorespiratory maturation and predictors of co-morbidity risk$578,223
U01 · FY2019 · HL · contact PI
Integrated analysis of autonomic biomarkers in prematurity-related ventilatory control: Determination of neurorespiratory maturation and predictors of co-morbidity risk$535,064
U01 · FY2018 · HL · contact PI
Autonomic Neurorespiratory Stability and Maturation in Preterm Infants: Assessment of Impact on Early Markers of Neurodevelopment$50,175
U01 · FY2018 · HL · contact PI
Integrated analysis of autonomic biomarkers in prematurity-related ventilatory control: Determination of neurorespiratory maturation and predictors of co-morbidity risk$545,870
U01 · FY2017 · HL · contact PI
Integrated analysis of autonomic biomarkers in prematurity-related ventilatory control: Determination of neurorespiratory maturation and predictors of co-morbidity risk$190,974
U01 · FY2016 · HL · contact PI
Influence of the Enteric Microbiome on the Genesis of Bronchopulmonary Dysplasia$469,426
U01 · FY2013 · HL · contact PI
Influence of the Enteric Microbiome on the Genesis of Bronchopulmonary Dysplasia$478,923
U01 · FY2012 · HL · contact PI
Influence of the Enteric Microbiome on the Genesis of Bronchopulmonary Dysplasia$476,998
U01 · FY2011 · HL · contact PI
Influence of the Enteric Microbiome on the Genesis of Bronchopulmonary Dysplasia$220,446
U01 · FY2010 · HL · contact PI
PROGRESSIVE LUNG DISEASE AND SURFACTANT DYSFUNCTION WITH A DELETION OF SURFACT$5,897
P41 · FY2006 · RR · contact PI
In Vivo Metabolism of Pulmonary Surfactant in Infants$256,000
R01 · FY2005 · HL
PROGRESSIVE LUNG DISEASE AND SURFACTANT DYSFUNCTION WITH A DELETION OF SURFACT$6,475
P41 · FY2005 · RR
PULMONARY DYSFUNCTION &INTEGRITY OF PULMONARY SURFACTANT SYSTEM$649
P41 · FY2005 · RR
In Vivo Metabolism of Pulmonary Surfactant in Infants$256,000
R01 · FY2004 · HL
PULMONARY DYSFUNCTION &INTEGRITY OF PULMONARY SURFACTANT SYSTEM$804
P41 · FY2004 · RR
In Vivo Metabolism of Pulmonary Surfactant in Infants$256,000
R01 · FY2003 · HL
In Vivo Metabolism of Pulmonary Surfactant in Infants$256,000
R01 · FY2002 · HL
In Vivo Metabolism of Pulmonary Surfactant in Infants$269,646
R01 · FY2001 · HL